MPLT
MapLight Therapeutics Inc.

65
Mkt Cap
$797.2M
Volume
185,615.00
52W High
$21.55
52W Low
$12.24
Price
$17.89
MPLT Fundamentals
Prev Close
$17.57
Open
$17.49
50D MA
$17.83
Beta
3.17
Avg. Volume
199,253.20
EPS (Annual)
-$1.87
P/B
-2.91
Loading...
Loading...
News
all
press releases
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Time to Sell?
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap Down - Time to Sell...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Recommendation of "Moderate Buy" from Brokerages
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) has been given an average rating of "Moderate Buy" by the six analysts that are presently covering the company, MarketBeat reports. One...
MarketBeat·6d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Director Sells $126,842.78 in Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) Director Robert Malenka sold 7,039 shares of the firm's stock in a transaction that occurred on Monday, February 2nd. The shares were sold...
MarketBeat·6d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Director Sells $119,743.32 in Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) Director Robert Malenka sold 6,612 shares of the firm's stock in a transaction on Friday, January 30th. The shares were sold at an average...
MarketBeat·11d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Director Robert Malenka Sells 6,524 Shares of Stock
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) Director Robert Malenka sold 6,524 shares of Maplight Therapeutics stock in a transaction that occurred on Wednesday, January 28th. The...
MarketBeat·11d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Director Robert Malenka Sells 21,262 Shares
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) Director Robert Malenka sold 21,262 shares of the business's stock in a transaction that occurred on Thursday, January 29th. The shares...
MarketBeat·11d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 4.8% - Still a Buy?
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 4.8% - Still a Buy...
MarketBeat·18d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 10.5% - Time to Buy?
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 10.5% - Here's What Happened...
MarketBeat·29d ago
News Placeholder
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Recommendation of "Buy" from Brokerages
Shares of Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) have been given an average rating of "Buy" by the six brokerages that are presently covering the firm, MarketBeat reports. One...
MarketBeat·1mo ago
News Placeholder
MapLight Therapeutics' Alzheimer's Psychosis Drug Granted FDA Fast Track Status
(RTTNews) - MapLight Therapeutics, Inc. (MPLT) on Monday said the U.S. Food and Drug Administration has granted Fast Track designation to ML-007C-MA for the treatment of hallucinations and delusions...
Nasdaq News: Markets·1mo ago
<
1
2
...
>

Latest MPLT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.